LONDON, May 10, 2017 -- Visiongain launches report on Manufacturing, Logistics and Distribution, Supply Chain Management, Packaging, Cold Chain Logistics.
Report Published in 20/02/2017
The Global Clinical Trial Supply and Logistics Market is expected to grow at a CAGR of 7.0% from 2016-2021 and CAGR of 5.6% from 2021-2027 says visiongain. The market is expected to grow at a CAGR of 6.2% from 2016 to 2027. The market is estimated at $14.84bn in 2016 and $28.75bn in 2027.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand, new 197-page report you will receive 120 charts – all unavailable elsewhere.
The 197-page report provides clear detailed insight into the Global Clinical Trial Supply and Logistics Market. Discover the key drivers and challenges affecting the pharma market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Revenue and growth forecasts to 2027 for the global clinical trial supply and logistics market
• Revenue and growth forecasts to 2027 for the leading segments of the global clinical trial supply and logistics market.
• Revenue and growth forecasts to 2027 for the leading countries
• Profiles the leading companies offering clinical trial supply and logistics services to the pharmaceutical industry
• Discusses the regulatory outlook for the clinical trial supply chain in the national markets.
• Provides qualitative analysis of the clinical trial supply and logistics market.
• Assesses the outlook for cold chain logistics in the clinical trial sector, as well as regulatory aspects of cold chain distribution for clinical trial materials
Individual sales predictions at world level to 2027 for the main submarkets:
• Manufacturing – also with sub forecasting for packaging and for other production
• Logistics and distribution – also with sub forecasts for cold chain logistics and for other services
• Supply chain management.
Individual revenue forecasts to 2027 by country:
• United States
• Japan
• Germany
• France
• United Kingdom
• Italy
• Spain
• Brazil
• Russia
• China
• India
• Rest of the World
Profiles of the leading companies offering clinical trial supply and logistics services to the pharmaceutical industry:
• World Courier
• DHL
• Marken
• TNT Express
• FedEx.
• Movianto
• Catalent.
• Patheon
• Almac Group
• Parexel International.
• Fisher Clinical Services
• Packaging Coordinators Inc.
Visiongain’s study is intended for anyone requiring commercial analyses for the global clinical trial supply and logistics market. You find data, trends and predictions.
Buy our report today Global Clinical Trial Supply and Logistics Market for Pharma 2017-2027: Manufacturing, Logistics and Distribution, Supply Chain Management, Packaging, Cold Chain Logistics.
To see a report overview please email [email protected] or for the full report Table of Contents please click on:
Companies listed in this report include:
Companies Listed
AbbVie Contract Pharmaceutical Manufacturing
Agência Nacional de Vigilância Sanitária (ANVISA)
Allergan
Almac Group
AmerisourceBergen
AMGEN
AndersonBrecon
Aptuit
Astellas Pharma
AstraZeneca.
Bellwyck Packaging Solutions
Boehringer Ingelheim
Bristol-Myers Squibb
British Telecom (BT)
Catalent Pharma Solutions
Celesio
Central Drugs Standard Control Organization (CDSCO)
China FDA (CFDA)
Chinese Ministry of Health
ClinIntel
Comissão Nacional de Ética em Pesquisa (CONEP)
Consorcio de Apoyo a la Investigación Biomédica – Plataforma Española de Ensayos Clínicos (CAIBER)
COREX
Cortec
Cryoport
DHL
Drug Controller General of India (DCGI)
Eli Lilly.
EMD SERONO
European Medicines Agency (EMA)
EPS
European Commission
Eurodifarm
Food and Drug Administration (FDA)
Federal Express (FedEx)
Fisher Clinical Services
Frazier Healthcare
GE Healthcare
Greenbox
GSK.
IMP Logistics
Intelsius
International Air Transport Association (IATA)
International Pharmaceutical Federation
Japanese Ministry of Health, Labour and Welfare (MHLW)
Johnson & Johnson
Komtur Pharmaceuticals
LabCorp
LCAG USA
LifeConEx
Lonza
Marken
Mawdsleys
Medgenics
Medicines and Healthcare Products Regulatory Agency (MHRA)
Merck & Co.
Mitsui & Co.
Movianto
National Institutes of Health (NIH)
Novo Nordisk
Novotech
Nuvilex
Octapharma
Owens & Minor
Parexel.
Patheon
Packaging Coordinators Inc. (PCI)
Perceptive Informatics
Pfizer.
Pharmaceuticals for Human Use (ICH)
Pieffe Group
Quintiles.
Recipharm.
Roche.
Sanofi.
SF Express
Thermo Fisher Scientific.
TNT Express
TransCelerate BioPharma
Transportation Administration Security (TAS)
Tufts Center
UCB
United Parcel Service (UPS)
US Pharmacopeia (USP)
World Courier
World Health Organization (WHO)
To see a report overview please email [email protected] or for the full TOC please click on:
Contact: Sara Peerun Phone Number: +44 (0) 208 7816960 Email: [email protected]


Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns
Airbus CEO Warns Staff to Prepare for Rising Geopolitical Risks Amid Trade Tensions
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris
Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 



